so i was recently working carpentry at the house of what i found out to be an old apochocaryist. up in one of the cieling boards, we found a little jar. that says cannabis etractum. E.R. Squibb and sons, New York, since 1858. its rock hard, because of how old it is. but i put some water in it and now its gooey, and it smells like olde bong water. i tryed burning a little piece, but it burns really wierdly and smells wierd. im not sure if this was intended to be eaten, or rubbed on the skin. i doubt it was meant to be smoked. i have found some but very little info about it on google. im basically trying to find a way to turn this into smokable hash. it says average dose one sixth of a grain. so it must be powerful. anyone know anything about this stuff. im sure its rare but i figured i would ask.

__________________
Hey Uncle Sam,
I am not a pot grower, i just think the girls look pretty... and smell good

dude dont mess with it anymore. that is a very very very unique artifact that could possibly be worth a few thousand dollars. lets see what kind of replies you get.

A Brief History of Bristol-Myers Squibb

Please click on product trade names to access Full Prescribing Information. This information is intended for U.S. residents only.
BRISTOL-MYERS

In 1887 William McLaren Bristol and John Ripley Myers decided to sink $5,000 into a failing drug manufacturing firm called the Clinton Pharmaceutical Company, located in Clinton, New York. The company was officially incorporated on December 13, 1887, with William Bristol as president and John Myers as vice president.

The partners worked hard to expand the business, but at first it was an uphill struggle. From the start, however, they had two rules: insist on high quality and maintain the firm’s good financial standing at all costs.

In May 1898 came a new name: Bristol, Myers Company (a hyphen would replace the comma after Myers’s death in 1899, when the company became a corporation). Not until 1900 did Bristol-Myers break through into the black -- where it has remained ever since.

The company’s first nationally recognized product was termed a poor man’s spa by chief chemist J. Leroy Webber: a laxative mineral salt that, when dissolved in water, reproduced the taste and effects of the natural mineral waters of Bohemia. Christened Sal Hepatica, the new product sold modestly for eight years. Then, from 1903 to 1905, sales suddenly mushroomed tenfold. Another runaway success of this era was Ipana toothpaste, the first toothpaste to include a disinfectant in its formula and thus protect against the effects of bleeding gums. The demand for Sal Hepatica and Ipana transformed Bristol-Myers from a regional into a national company and then an international one.

In 1924, gross profits topped $1 million for the first time in Bristol-Myers’ history. The company’s products were now sold in 26 countries. At this point, the shares held by John Myers’s heirs became available for sale, triggering a series of moves that in 1929 turned Bristol-Myers into a publicly held company, listed on the New York Stock Exchange.
The postwar depression prompted Bristol-Myers to jettison its pharmaceutical business and devote itself entirely to its specialties: Sal Hepatica and Ipana, its two big winners, and a dozen or so assorted toiletries, antiseptics and cough syrups. Company headquarters were established in Manhattan. And having shifted squarely into the consumer products arena, Bristol-Myers began advertising its products directly to the public.

With the acquisition in 1943 of Cheplin Laboratories -- a Syracuse, New York manufacturer of acidophilus milk -- Bristol-Myers again became a producer of pharmaceutical products. Cheplin, which had expertise in fermentation techniques, became a key supplier to the U.S. War Production Board’s crash program to mass-produce penicillin for the Allied armed forces.
By the end of the war, it was clear that penicillin and other antibiotics represented an immense opportunity for Bristol-Myers. Cheplin was renamed Bristol Laboratories, and Frederic N. Schwartz was put in charge of it.

In 1957 Schwartz was appointed president and chief executive officer of Bristol-Myers when Henry Bristol, approaching 70, chose to shed some of his former responsibilities and become chairman of the board.

Reviewing the company’s situation and prospects, Schwartz and then-treasurer Gavin K. MacBain -- later Schwartz’s successor as CEO -- decided that Bristol-Myers should embark on a program of acquiring well-managed smaller companies. The two executives’ first major move in that direction was to acquire Clairol, a company founded by the husband-and-wife team of Lawrence M. Gelb and Joan Clair, which had turned haircoloring from a difficult-to-use specialty item into a highly successful mainstream consumer product. With Clairol also came the executive who in 1972 was to succeed MacBain as CEO of Bristol-Myers Company: Richard L. Gelb, elder son of Clairol’s founders. In 1976 Richard Gelb was elected chairman of the board.

Within a dozen or so years after Clairol joined the company, a number of other acquisitions followed, including those of Drackett, Mead Johnson, Zimmer and Westwood.

In 1986 the company opened a state-of-the-art research complex in Wallingford, Connecticut, designed to house more than 800 scientists and support staff. (In 1995, this facility would be renamed the Richard L. Gelb Center for Pharmaceutical Research and Development.)


SQUIBB

In 1858 Edward Robinson Squibb founded a pharmaceutical company in Brooklyn, New York, dedicated to the production of consistently pure medicines.

In 1895 Squibb passed most of the responsibility for managing the firm to his sons, Charles and Edward. The company became known as E.R. Squibb & Sons.

In 1905 the Squibb sons sold the company to Lowell M. Palmer and Theodore Weicker, and the company became incorporated. That same year, land was purchased at New Brunswick, New Jersey, for establishment of an ether production plant.

In 1906, six years after Edward Squibb’s death, Congress passed the Pure Food and Drugs Act. The law still stands as the triumph of his lifelong crusade for safe, reliable pharmaceutical products.
Around the same time, the prototype of the Squibb logo was designed. The logo represented product uniformity, purity, efficacy and reliability based on research.

In 1921 the company coined its slogan: "The priceless ingredient in every product is the honor and integrity of its maker."

In 1938 the Squibb Institute for Medical Research was established.

In 1944 Squibb opened the largest penicillin production plant in the world; in New Brunswick, New Jersey.

In 1946 Squibb International was incorporated and the company expanded into South America and Europe while building manufacturing facilities in Mexico, Italy and Argentina.

In 1971 Squibb Corporation established worldwide headquarters and expanded facilities for the Squibb Institute in Princeton, New Jersey.

In 1975 Squibb researchers Miguel A. Ondetti, Bernard Rubin and David W. Cushman created Capoten® (captopril) -- the first in a new class of antihypertensive agents called ACE inhibitors. Capoten was an important new medical discovery for the treatment of patients with high blood pressure. In 1999, Cushman and Ondetti would be honored further with the prestigious Lasker Award.

A Pharmaceutical Product Catalog
E. R. Squibb & Sons (1919)
Chapter 13


13.1 - Squibb's Materia Medica (1919 edition) Product Catalog:
Old pharmaceutical product catalogs can provide a wealth of information. Obviously, their main use for the antique collector today, is to help identify and find pre-1940 medical Cannabis products. But they also seem to have the power to allow us to travel back in time, literally, they can take us right into the very minds and lives of the pharmacists who were making these drugs themselves.

To demonstrate this point, we've chosen (at random) to reproduce selected parts of the E. R. Squibb's & Sons Co., (1919 edition) pharmaceutical houses product and price catalog.

Please keep in mind, that NO attempt will be made to list all Cannabis product references; No veterinary (see chapter 14) products are shown etc.
</B>E.R. Squbb & Sons:
Price & Product Catalog
Selected [Cannabis Related] Pages



From Page 39


From Page 82


From Page 96 Quote: Old pharmaceutical product catalogs can provide a wealth of information. Obviously, their main use for the antique collector today, is to help identify and find pre-1940 medical Cannabis products

Knowing that THC degrades with heat over time, i'd bet the physoactive properties of that product are gone.

great novelty item though. maybe worth something.

ya i was thinking it could be worth alot. its almost impossible to find anymore information on it, from any angle other than the stuff panda found. i found some of that same shit, but it doesnt reeally even tell you how to ingest it or anything.

__________________
Hey Uncle Sam,
I am not a pot grower, i just think the girls look pretty... and smell good

I think i found your jar is it the one in the bottom middle?

MIGRAINE HEADACHE / POWDERED CANNABIS
Eli Lilly

Eli Lilly

Eli Lilly

Eli Lilly

Merrel

ParkeDavis

SmithKline

Squibb

WyethBrother

WyethBrother

no its none of those

__________________
Hey Uncle Sam,
I am not a pot grower, i just think the girls look pretty... and smell good

I've dealt in some medical collectibles of that same type . It's more likely in the hundreds than the thousands.

Ebay is always a good place to research this type of thing as far as values. May not find the exact item, but similar for price comparison.

__________________
Check it out, let me know what you think.

http://www.rollitup.org/grow-journal...park-grow.html

from the description on the bottle; narcotic, sedative, i bet it was a powder that you mixed into a liquid as a sleep aid.